Maternal age influences risk for HLA-B27 associated ankylosing enthesopathy in transgenic mice.

AUTOR(ES)

Weinreich, S

RESUMO

OBJECTIVE--To study further the temporal clustering of ankylosing enthesopathy (AE) noted originally during a study of the influence of mouse major histocompatibility complex (MHC) H-2 and transgenic HLA-B27 on the frequency of AE. METHODS--The relationship between maternal age at littering and frequency of AE was analysed. RESULTS--Mice born to mothers aged eight months or older had a significantly lower disease frequency of AE than mice born to mothers younger than eight months of age. This phenomenon was observed in three independent cohorts evaluated to date (p < 0.01, 0.025, and 0.05). CONCLUSION--Maternal age is a novel, non-genetic risk factor as defined in relation to an MHC associated enthesopathy. Its mode of action and relevance to human disease require further investigation.

Documentos Relacionados

• Isolated HLA-B27 associated Achilles tendinitis.
• Longstanding HLA-B27 associated Achilles tendinitis.
• Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.
• Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis
• Heart conduction disturbance: an HLA-B27 associated disease.